NACDS Expresses Support for Congressional Agreement on Comprehensive Supply Chain and Compounding Legislation

Published Online: Friday, September 27, 2013
Follow Pharmacy_Times:
PRESS RELEASE

September 27, 2013 (Arlington, Va.) – The National Association of Chain Drug Stores (NACDS) today endorsed the agreement reached by the U.S. Senate and U.S. House of Representatives on comprehensive supply chain and compounding legislation.  In a letter to congressional leaders, NACDS said the agreement makes strong efforts to ensure the health and safety of the American public.

“We believe [the agreement] will help guarantee patient safety through a more secure supply chain and appropriate and improved oversight of compounding activities,” NACDS stated in the letter.  “We believe that the reforms contained within the legislation meet the overarching goal of protecting patients while allowing chain pharmacies to operate effectively and efficiently in dispensing needed medications.”  

Specifically, NACDS noted that the bill establishes one national standard for supply chain regulation as opposed to an unworkable patchwork of state laws and regulations. 

“Chain pharmacy has made significant investments to ensure that the U.S. pharmaceutical distribution system is one of the safest in the world and your legislation will only improve and strengthen the process for all stakeholders,” the letter stated.

In addition, NACDS cited the agreement’s clarification and call for an additional regulatory track for sterile compounding to help safeguard patient safety.  “This is a large step in helping avoid tragedies such as last year’s national meningitis outbreak.  At the same time, we appreciate the agreement’s protection of traditional compounding practices largely performed by retail pharmacists,” NACDS stated in the letter.

“As the House and Senate debate on the agreement, NACDS will continue to urge lawmakers to pass this legislation so it can be signed into law to improve protections for patients,” NACDS stated.

Related Articles
Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how pharmacists' awareness of sterile compounding procedures has changed since the 2012 meningitis outbreak.
The National Association of Chain Drug Stores lends its support to S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
The value of collaboration through the National Association of Chain Drug Stores was on display today, as the NACDS Regional Chain Conference explored business-to-business partnerships and a public policy agenda that benefits patients and consumers.
A proposal in the Budget of the U.S. Government, Fiscal Year 2016 to increase prescription drug co-payments for TRICARE beneficiaries met with concern by the National Association of Chain Drug Stores.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$